{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:06:28Z","timestamp":1788444388609,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R61AI136002"],"award-info":[{"award-number":["R61AI136002"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI162246"],"award-info":[{"award-number":["R01AI162246"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI150358"],"award-info":[{"award-number":["R01AI150358"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jconrel.2024.10.059","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T07:54:12Z","timestamp":1731398052000},"page":"1209-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy"],"prefix":"10.1016","volume":"376","author":[{"given":"Denali K.","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Janusziewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopali","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanon","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie L.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda P.","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.M.","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rahima","family":"Benhabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.10.059_bb0005","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","article-title":"Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019","volume":"8","author":"Bearak","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0010","series-title":"Global HIV & AIDS Statistics \u2014 Fact Sheet","year":"2020"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0015","series-title":"Sexually Transmitted Infections (STIs) - Fact Sheet","year":"2020"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0020","series-title":"Contraceptive Use by Method","year":"2024"},{"issue":"4","key":"10.1016\/j.jconrel.2024.10.059_bb0025","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1016\/S2214-109X(20)30060-7","article-title":"Trends in sexual activity and demand for and use of modern contraceptive methods in 74 countries: a retrospective analysis of nationally representative surveys. The Lancet Global Health, 2020","volume":"8","author":"Slaymaker","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0030","series-title":"WHO Massive Proportion of World\u2019s Population are Living with Herpes Infection","year":"2020"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1473-3099(17)30405-X","article-title":"Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis","volume":"17","author":"Looker","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001875","article-title":"The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study","volume":"5","author":"Looker","year":"2020","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(19)30470-0","article-title":"Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data","volume":"20","author":"Looker","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.12842","article-title":"The need for multipurpose prevention technologies in sub-Saharan Africa","volume":"121","author":"Abdool Karim","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0055","series-title":"World Health Organization Sexual and Reproductive Health","author":"WHO Multipurpose Prevention Technologies (MPTs)","year":"2021"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1071\/SH11011","article-title":"Progress and challenges to male and female condom use in South Africa","volume":"9","author":"Beksinska","year":"2011","journal-title":"Sex. Health"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1071\/SH11033","article-title":"Condoms in sub-Saharan Africa","volume":"9","author":"Maticka-Tyndale","year":"2012","journal-title":"Sex. Health"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/IJWH.S185712","article-title":"\u201cWe are not the same\u201d: African women\u2019s view of multipurpose prevention products in the TRIO clinical study","volume":"11","author":"Mary Kate Shapley Quinn","year":"2019","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0075","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing Dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25634","article-title":"Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial","volume":"23","author":"Brown","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0085","author":"WHO"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0090","author":"WHO"},{"issue":"Suppl","key":"10.1016\/j.jconrel.2024.10.059_bb0095","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.antiviral.2013.09.030","article-title":"Multipurpose prevention technologies: products in development","volume":"100","author":"Friend","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0010-7824(79)90065-9","article-title":"Low-level, progestogen-releasing vaginal contraceptive devices","volume":"19","author":"Burton","year":"1979","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0010-7824(78)90013-6","article-title":"Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroids","volume":"17","author":"Burton","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0039-128X(00)00175-6","article-title":"Progestin-only contraceptive rings","volume":"65","author":"Brache","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0115","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2010.04.012","article-title":"Contraceptive vaginal rings: a review","volume":"82","author":"Brache","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.contraception.2012.08.037","article-title":"Current status of contraceptive vaginal rings","volume":"87","author":"Brache","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275794","article-title":"Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: the CONRAD 138 study","volume":"17","author":"Thurman","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0130","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/AAC.02641-14","article-title":"Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor Pritelivir following treatment of wild-type or Pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model","volume":"58","author":"Biswas","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"23","key":"10.1016\/j.jconrel.2024.10.059_bb0135","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of Pritelivir compared with acyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trial","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jconrel.2024.10.059_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202000261","article-title":"Design and characterization of a novel series of geometrically complex intravaginal rings with digital light synthesis","volume":"5","author":"Janusziewicz","year":"2020","journal-title":"Adv. Mater. Technol."},{"issue":"100978","key":"10.1016\/j.jconrel.2024.10.059_bb0145","first-page":"1","article-title":"Fundamental investigation of sustained and controlled therapeutics release from 3D printed devices","volume":"24","author":"Rima Janusziewicz","year":"2022","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/157016206778560045","article-title":"Animal models used for the evaluation of antiretroviral therapies","volume":"4","author":"Dias","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pharmtox.48.113006.094906","article-title":"Topical microbicides to prevent HIV: clinical drug development challenges","volume":"49","author":"Hendrix","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2009.07.008","article-title":"Evaluation of antiretrovirals in animal models of HIV infection","volume":"85","author":"Van Rompay","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/aid.2011.0234","article-title":"The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies","volume":"28","author":"Van Rompay","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0170","series-title":"InTech","author":"Lara","year":"2012"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0684.2011.00488.x","article-title":"Development of a pigtail macaque model of sexually transmitted infection\/HIV coinfection using Chlamydia trachomatis, trichomonas vaginalis, and SHIVSF162P3","volume":"40","author":"Henning","year":"2011","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0180","first-page":"5952","article-title":"Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques","volume":"56","author":"Moss","year":"2012"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185946","article-title":"Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: pharmacokinetic evaluation in a macaque model","volume":"12","author":"Smith","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0190","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1128\/AAC.02871-14","article-title":"Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model","volume":"58","author":"Moss","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0195","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/AAC.05721-11","article-title":"Safe and sustained vaginal delivery of Pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings","volume":"56","author":"Johnson","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0200","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0684.2009.00354.x","article-title":"Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates","volume":"38","author":"Promadej-Lanier","year":"2009","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/jmp.12119","article-title":"Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use","volume":"43","author":"Srinivasan","year":"2014","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1258\/002367781780953059","article-title":"Characteristics of the menstrual cycle in nonhuman primates. IV. Timed mating in Macaca nemestrina","volume":"15","author":"Blakley","year":"1981","journal-title":"Lab. Anim."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202000261","article-title":"Design and characterization of a novel series of geometrically complex intravaginal rings with digital light synthesis","volume":"5","author":"Janusziewicz","year":"2020","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0220","article-title":"Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy","volume":"301","author":"Isabella","year":"2023","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2024.10.059_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0230","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1208\/s12249-013-9960-2","article-title":"Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions","volume":"14","author":"Liu","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0235","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council, N.R","year":"2011"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0240","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1128\/AAC.00082-16","article-title":"Safety and pharmacokinetics of quick-dissolving polymeric vaginal films delivering the antiretroviral IQP-0528 for preexposure prophylaxis","volume":"60","author":"Srinivasan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAI.0b013e318220ebd3","article-title":"High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques","volume":"57","author":"Vishwanathan","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.jconrel.2024.10.059_bb0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0684.2011.00516.x","article-title":"A guide for standardizing colposcopic observations for the evaluation of topical microbicide products in the pigtailed macaque model","volume":"41","author":"DL","year":"2012","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0255","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.antiviral.2013.09.025","article-title":"Development of dapivirine vaginal ring for HIV prevention","volume":"100","author":"Devlin","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0260","series-title":"Summary of Product Characteristics: Dapivirine Vaginal Ring 25mg","author":"Agency","year":"2020"},{"issue":"22","key":"10.1016\/j.jconrel.2024.10.059_bb0265","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing Dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2024.10.059_bb0270","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/humrep\/dew145","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a phase 1 randomized controlled trial","volume":"31","author":"Schultze-Mosgau","year":"2016","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jconrel.2024.10.059_bb0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial: I. Contraceptive efficacy and side effects","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.jconrel.2024.10.059_bb0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0010-7824(85)90016-2","article-title":"Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel","volume":"32","author":"Xiao","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","article-title":"Helicase\u2013primase inhibitor pritelivir for HSV-2 infection","volume":"370","author":"Wald","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0290","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of Pritelivir compared with Valacyclovir on genital HSV-2 shedding in patients with frequent recurrences","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jconrel.2024.10.059_bb0295","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/09564624211006568","article-title":"Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2","volume":"32","author":"Cannon","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0300","article-title":"Matrix-based controlled release delivery of acyclovir from poly-(ethylene co-vinyl acetate) rings","volume":"55","author":"Giannasca","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0305","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.05662-11","article-title":"Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring","volume":"56","author":"Moss","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0310","first-page":"875","article-title":"Simultaneous delivery of Tenofovir and acyclovir via an intravaginal ring","author":"Moss","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0315","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2019.10.015","article-title":"In vitro release testing methods for drug-releasing vaginal rings","volume":"313","author":"Boyd","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0320","article-title":"Benhabbour Next generation 3D printed multipurpose intravaginal ring for the sustained co-delivery of antiretrovirals and contraceptive drugs","author":"Dahl","year":"2024","journal-title":"Drug Deliv. Transl. Res. (Submitted)"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0325","series-title":"Lack of In Vitro-In Vivo Correlation for a UC781-Releasing Vaginal Ring in Macaques","author":"Friend","year":"2015"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0330","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00007435-199611000-00009","article-title":"The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem","volume":"23","author":"Patton","year":"1996","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0335","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/AAC.02336-13","article-title":"Pharmacokinetic and safety analyses of tenofovir and tenofovir-emtricitabine vaginal tablets in pigtailed macaques","volume":"58","author":"Pereira","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2015.06.018","article-title":"A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy","volume":"213","author":"Ugaonkar","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0345","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.08.051","article-title":"Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques","volume":"550","author":"Murphy","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12010001","article-title":"Rational design of a multipurpose Bioadhesive Vaginal film for co-delivery of Dapivirine and Levonorgestrel","volume":"12","author":"Li","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.10.059_bb0355","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a Dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25747","article-title":"Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States","volume":"24","author":"Liu","year":"2021","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.jconrel.2024.10.059_bb0365","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2015.06.018","article-title":"A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy","volume":"213","author":"Ugaonkar","year":"2015","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924007326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924007326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T08:38:00Z","timestamp":1733560680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924007326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":73,"alternative-id":["S0168365924007326"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.059","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}